| 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines … BR Haugen, EK Alexander, KC Bible, GM Doherty, SJ Mandel, ... Thyroid 26 (1), 1-133, 2016 | 15768 | 2016 |
| Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association (ATA … DS Cooper, GM Doherty, BR Haugen, RT Kloos, SL Lee, SJ Mandel, ... Thyroid 19 (11), 1167-1214, 2009 | 8250 | 2009 |
| Management guidelines for patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Taskforce DS Cooper, GM Doherty, BR Haugen, RT Kloos, SL Lee, SJ Mandel, ... Thyroid 16 (2), 109-142, 2006 | 3213 | 2006 |
| Integrated genomic characterization of papillary thyroid carcinoma N Agrawal, R Akbani, BA Aksoy, A Ally, H Arachchi, SL Asa, JT Auman, ... Cell 159 (3), 676-690, 2014 | 2771 | 2014 |
| Lenvatinib versus placebo in radioiodine-refractory thyroid cancer M Schlumberger, M Tahara, LJ Wirth, B Robinson, MS Brose, R Elisei, ... New England Journal of Medicine 372 (7), 621-630, 2015 | 2144 | 2015 |
| Management of Thyroid Nodules Detected at US: Society of Radiologists in Ultrasound Consensus Conference Statement1 MC Frates, CB Benson, JW Charboneau, ES Cibas, OH Clark, ... Radiology 237 (3), 794-800, 2005 | 1946 | 2005 |
| Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial MS Brose, CM Nutting, B Jarzab, R Elisei, S Siena, L Bastholt, ... The Lancet 384 (9940), 319-328, 2014 | 1811* | 2014 |
| Thyroid carcinoma SI Sherma The Lancet 361 (9356), 501-511, 2003 | 1706 | 2003 |
| Cabozantinib in progressive medullary thyroid cancer R Elisei, MJ Schlumberger, SP Müller, P Schöffski, MS Brose, MH Shah, ... Journal of clinical oncology 31 (29), 3639-3646, 2013 | 1322 | 2013 |
| Outcomes of patients with differentiated thyroid carcinoma following initial therapy J Jonklaas, NJ Sarlis, D Litofsky, KB Ain, ST Bigos, JD Brierley, ... Thyroid 16 (12), 1229-1242, 2006 | 910 | 2006 |
| A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma EL Mazzaferri, RJ Robbins, CA Spencer, LE Braverman, F Pacini, ... The Journal of Clinical Endocrinology & Metabolism 88 (4), 1433-1441, 2003 | 875 | 2003 |
| A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer BR Haugen, F Pacini, C Reiners, M Schlumberger, PW Ladenson, ... The Journal of Clinical Endocrinology & Metabolism 84 (11), 3877-3885, 1999 | 801 | 1999 |
| Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer MA Kouvaraki, SE Shapiro, BD Fornage, BS Edeiken-Monro, SI Sherman, ... Surgery 134 (6), 946-954, 2003 | 759 | 2003 |
| Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer R Kurzrock, SI Sherman, DW Ball, AA Forastiere, RB Cohen, R Mehra, ... Journal of Clinical Oncology 29 (19), 2660-2666, 2011 | 643 | 2011 |
| Motesanib diphosphate in progressive differentiated thyroid cancer SI Sherman, LJ Wirth, JP Droz, M Hofmann, L Bastholt, RG Martins, ... New England Journal of Medicine 359 (1), 31-42, 2008 | 592 | 2008 |
| Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized … F Pacini, PW Ladenson, M Schlumberger, A Driedger, M Luster, RT Kloos, ... The Journal of Clinical Endocrinology & Metabolism 91 (3), 926-932, 2006 | 589 | 2006 |
| Prospective multicenter study of thyroid carcinoma treatment: initial analysis of staging and outcome SI Sherman, JD Brierley, M Sperling, KB Ain, ST Bigos, DS Cooper, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 1998 | 558 | 1998 |
| Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry DS Cooper, B Specker, M Ho, M Sperling, PW Ladenson, DS Ross, ... Thyroid 8 (9), 737-744, 1998 | 485 | 1998 |
| Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or … H Hänscheid, M Lassmann, M Luster, SR Thomas, F Pacini, C Ceccarelli, ... Journal of Nuclear Medicine 47 (4), 648-654, 2006 | 428 | 2006 |
| Incretin-based therapies for the treatment of type 2 diabetes: evaluation of the risks and benefits DJ Drucker, SI Sherman, FS Gorelick, RM Bergenstal, RS Sherwin, ... Diabetes care 33 (2), 428, 2010 | 420 | 2010 |
